
Originally Posted by
Kembal
Yeah, no. Without debating your specific hypothetical (which has a hole so large in it I could drive a truck through), cost-effectiveness doesn't mean that. It does mean that if a pharmaceutical company develops a new treatment that is no more effective than current treatments but costs five times more, it probably shouldn't be covered.
This probably wouldn't be an issue if pharmaceutical companies weren't allowed to do consumer marketing like previously, but since they are, it's now important to do so.